Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2003
10/09/2003WO2003082905A1 Plant retroviral polynucleotides and methods for use thereof
10/09/2003WO2003082904A2 Modified aequorins having enhanced glowing kinetics and methods of using same
10/09/2003WO2003082902A2 Novel corticotropin-releasing hormone analogs
10/09/2003WO2003082900A2 Self-assembling-peptide-based structures and processes for controlling the self-assembly of such structures
10/09/2003WO2003082898A2 Novel analogues of glucose-dependent insulinotropic polypeptide
10/09/2003WO2003082897A2 Synthetic active peptide fragments
10/09/2003WO2003082802A1 Acid and ester compounds and methods of using the same
10/09/2003WO2003082349A1 Treatment methods for eotaxin mediated inflammatory conditions
10/09/2003WO2003082345A1 Drugs comprising protein forming hollow nanoparticles and therapeutic substance to be transferred into cells fused therewith
10/09/2003WO2003082344A1 Remedies with the use of hollow protein nanoparticles presenting growth factor or the like
10/09/2003WO2003082342A1 Application of kiaa0172 gene to treatment and diagnosis of diseases and drug discovery
10/09/2003WO2003082331A1 Decoy compositions for treating and preventing brain diseases and disorders
10/09/2003WO2003082330A1 Therapeutic drug using antibody-presenting hollow protein nanoparticles and hollow protein nanoparticles
10/09/2003WO2003082329A2 Compositions and compounds for use as molecular adjuvant for a nicotine vaccine
10/09/2003WO2003082328A1 Use of discoidin domain receptor 1 (ddr1) and agents that affect the ddr1/collagen pathway
10/09/2003WO2003082320A1 Novel screening method
10/09/2003WO2003082200A2 Potent oncolytic herpes simplex virus for cancer therapy
10/09/2003WO2003082079A2 Diagnostics for the detection of acidovorax avenae subsp. citrulli, causal agent of bacterial fruit blotch in melons
10/09/2003WO2003081996A2 Non-human transgenic mammals carrying germile mutations in both the p53 andfos genes and their use as a disease model
10/09/2003WO2003081993A2 Transgenic aves producing human polyclonal antibodies
10/09/2003WO2003081988A2 Generation of plants with improved drought tolerance
10/09/2003WO2003081978A2 Generation of plants with improved pathogen resistance
10/09/2003WO2003057731A3 Human pheromone receptors
10/09/2003WO2003054003A3 Human tid isoforms associated with pathophysiological processes
10/09/2003WO2003052068A3 Mbcats as modifiers of the beta-catenin pathway and methods of use
10/09/2003WO2003050263A3 Dna encoding orphan snorf49 receptor
10/09/2003WO2003046005A3 Interalpha trypsin inhibitor biopolymer markers indicative of insulin resistance
10/09/2003WO2003037367A3 New bacterium causing poultry disease and vaccine derived thereof
10/09/2003WO2003035686A3 Compositions of fsh with high sialylation degree and their use for the preparation of medicaments
10/09/2003WO2003034981A3 Prevention of recurrent viral disease
10/09/2003WO2003028621A3 Proteinase inhibitors for treating and diagnosing neurodegenerative diseases
10/09/2003WO2003028432A3 Flexible processing apparatus for isolating and purifying viruses, soluble proteins and peptides from plant sources
10/09/2003WO2003024389A3 T. reesei phytase enyzmes, polynucleides encoding the enzymes, vectors and host cells thereof, and methods of using
10/09/2003WO2003023012A3 Crystal structure of interleukin-22 and uses thereof
10/09/2003WO2003022880A3 Synthetic hcv envelope proteins and their use for vaccination
10/09/2003WO2003020758A3 Cdk regulator proteins called ringo
10/09/2003WO2003016341A3 Regulation of iron uptake
10/09/2003WO2003014149A3 Genetically modified cyclic-nucleotide controlled ion channels and the use thereof
10/09/2003WO2003014076A3 Bi-directional synthesis of oligoguanidine transport agents
10/09/2003WO2003013224A3 Herbicide tolerant cotton plants and methods for producing and identifying same
10/09/2003WO2003012133A3 Isp-1 and ctb-1 genes and uses thereof
10/09/2003WO2003008437A3 Protein and nucleic acid expression systems
10/09/2003WO2003007889A3 Therapeutic agents comprising pro-apoptotic proteins
10/09/2003WO2003006481A3 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
10/09/2003WO2003002754A3 Bri constructs and methods of using
10/09/2003WO2003002599A3 Immune-related proteins and the regulation of the same
10/09/2003WO2003001880A3 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
10/09/2003WO2003000878A3 Use of fkbp chaperones as expression tool
10/09/2003WO2003000865A3 Human secreted proteins
10/09/2003WO2002097038A3 Chemokine beta-1 fusion proteins
10/09/2003WO2002092011A3 Methods of treating antibody-mediated pathologies using agents which inhibit cd21
10/09/2003WO2002092004A3 Use of hmg fragment as anti-inflammatory agents
10/09/2003WO2002087503A3 Compositions and methods for treating colorectal polyps and cancer
10/09/2003WO2002085942A3 A 150 kda tgf-beta 1 accessory receptor acting as a negative modulator of tgf-beta signaling
10/09/2003WO2002070744A3 Adenoviral library assay for e2f regulatory genes and methods and compositions for screening compounds
10/09/2003WO2002070701A3 Novel human gnrh receptor
10/09/2003WO2002069947A3 Antisense oligonucleotides and trichostatin analogue histone deacetylase-4 inhibitors against cancer
10/09/2003WO2002059381A3 Gene for identifying individuals with familial dysautonomia
10/09/2003WO2002059315A3 Human nucleic acids and polypeptides and methods of use thereof
10/09/2003WO2002056905A3 Molecular antigen array
10/09/2003WO2002055063A3 Fumaric acid amides
10/09/2003WO2002053743A3 Mammalian tribbles signaling pathways and methods and reagents related thereto
10/09/2003WO2002046218A3 Treatment of disease by inducing cell apoptosis
10/09/2003WO2002043759A3 Method and composition for modulating bone growth
10/09/2003WO2002040676A3 Mutant allergens
10/09/2003WO2002034791A3 Methods of purification and recovery of interferon-beta
10/09/2003WO2002032449A3 Method for treating ischemic events affecting the central nervous system
10/09/2003WO2002029072A3 Targetting molecules for adenoviral vectors
10/09/2003WO2002024940A3 Means for the identification of compounds capable of inhibiting karap-transduced signals
10/09/2003WO2002022664A3 Antigenic proteins of shrimp white spot syndrome virus and uses thereof
10/09/2003WO2002020563A3 RECEPTOR IN THE EDb FIBRONECTIN DOMAIN
10/09/2003WO2002016612A3 Genes and proteins, and their uses
10/09/2003WO2002016434A9 T CELL RECEPTOR Vβ-Dβ-Jβ SEQUENCE AND METHODS FOR ITS DETECTION
10/09/2003WO2002012290A3 Sid polypeptides binding to pathogenic strain of the hepatitis c virus
10/09/2003WO2002010382A3 Trp8, trp9 and trp10, markers for cancer
10/09/2003WO2002006313A3 Regulation of human glutamate receptor delta-1 subunit
10/09/2003US20030192078 Modifying a wild-type structural gene sequence encoding an insecticidal protein of Bacillus thuringiensis to enhance the expression of protein in plants by removing polyadenylation signals and retaining a sequence which codes such protein
10/09/2003US20030192077 Production of silk-like proteins in plants
10/09/2003US20030192076 Obtaining a population of plants transformed to express a polypeptide having a specific amino acid sequence, growing such plants under the growth limiting condition to detect such plants having enhanced growth and/or fruit yield
10/09/2003US20030192075 Elicitor from cladosporium
10/09/2003US20030192074 Encoding an MLA polypeptide which is capable of recognising and activating a race specific defense response in a plant into which the nucleic acid is introduced and expressed, in response to challange with a congnate Erysiphe graminis
10/09/2003US20030192068 Production of recombinant polypeptides by bovine species and transgenic methods
10/09/2003US20030192067 Delivery system
10/09/2003US20030192066 DNA molecule containing an adenoviral inverted terminal repeat (ITR), a packaging signal, a transcriptional control region, effector or reporter gene, generating an infectious, replication-defective genetic engineered adenoviral vector
10/09/2003US20030192065 Human nerve growth factor exon 1 and exon 3 promoters
10/09/2003US20030191301 Nucleic acid molecule encoding a gene product which, when knocked out, or prevented from expression results in a high growth phenotype
10/09/2003US20030191299 PRO polypeptides fused to heterologous polypeptide sequences
10/09/2003US20030191298 Transcription factor polynucleotides, polypeptides, antibodies, and methods based thereon
10/09/2003US20030191297 Avian ghd genes and their use in methods for sex identification in birds
10/09/2003US20030191292 Of viruses from solution containing macromolecules; increased salt content; reduces residence time
10/09/2003US20030191291 Synthetic erythropoiesis stimulating proteins
10/09/2003US20030191290 Antibody that binds to the protein; given amino acid sequence
10/09/2003US20030191289 Antibody that binds to the protein; given amino acid sequence
10/09/2003US20030191288 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/09/2003US20030191287 Antibody that binds to the protein; given amino acid sequence
10/09/2003US20030191285 Novel g protein-coupled receptor proteins and dnas thereof
10/09/2003US20030191284 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/09/2003US20030191283 Nsp molecules
10/09/2003US20030191282 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/09/2003US20030191281 Of given amino acid sequence; culturing host cells transformed with vector
1 ... 1513 1514 1515 1516 1517 1518 1519 1520 1521 1522 1523 1524 1525 1526 1527 1528 1529 1530 1531 1532 1533 ... 2916